Professional Advisory Services’s Pfizer PFE Stock Holding History

Professional Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$566K	Buy	23,492 +100	+0.4%	+$2.62K	0.07%	58
2026 Q1	$657K	Hold	23,392	–	–	0.09%	51
2025 Q4	$582K	Sell	23,392 -800	-3%	-$20.2K	0.08%	55
2025 Q3	$616K	Sell	24,192 -200	-0.8%	-$4.94K	0.08%	55
2025 Q2	$591K	Sell	24,392 -206	-0.8%	-$4.8K	0.08%	50
2025 Q1	$623K	Sell	24,598 -462	-2%	-$12.1K	0.09%	52
2024 Q4	$665K	Sell	25,060 -300	-1%	-$8.14K	0.09%	45
2024 Q3	$734K	Sell	25,360 -6	-0%	-$175	0.1%	45
2024 Q2	$710K	Hold	25,366	–	–	0.1%	44
2024 Q1	$704K	Buy	25,366 +206	+0.8%	+$5.72K	0.1%	44
2023 Q4	$724K	Buy	25,160 +150	+0.6%	+$4.53K	0.1%	41
2023 Q3	$830K	Sell	25,010 -2,450	-9%	-$86.6K	0.14%	39
2023 Q2	$1.01M	Sell	27,460 -10	-0%	-$389	0.15%	38
2023 Q1	$1.12M	Hold	27,470	–	–	0.17%	37
2022 Q4	$1.41M	Sell	27,470 -375	-1%	-$18K	0.23%	36
2022 Q3	$1.22M	Sell	27,845 -250	-0.9%	-$12.1K	0.21%	37
2022 Q2	$1.47M	Buy	28,095 +100	+0.4%	+$5.1K	0.25%	36
2022 Q1	$1.45M	Hold	27,995	–	–	0.21%	36
2021 Q4	$1.65M	Buy	27,995 +820	+3%	+$40.6K	0.22%	35
2021 Q3	$1.17M	Buy	27,175 +245	+0.9%	+$10.9K	0.17%	36
2021 Q2	$1.05M	Buy	26,930 +1,485	+6%	+$57.7K	0.15%	36
2021 Q1	$922K	Buy	25,445 +100	+0.4%	+$3.55K	0.14%	38
2020 Q4	$933K	Sell	25,345 -1,733	-6%	-$63.6K	0.15%	36
2020 Q3	$943K	Buy	27,078 +786	+3%	+$27.6K	0.17%	36
2020 Q2	$816K	Buy	26,292 +105	+0.4%	+$3.57K	0.16%	35
2020 Q1	$811K	Sell	26,187 -26	-0.1%	-$886	0.19%	35
2019 Q4	$974K	Hold	26,213	–	–	0.17%	39
2019 Q3	$894K	Hold	26,213	–	–	0.17%	39
2019 Q2	$1.08M	Sell	26,213 -26	-0.1%	-$1.03K	0.21%	38
2019 Q1	$1.06M	Sell	26,239 -16	-0.1%	-$641	0.21%	38
2018 Q4	$1.09M	Hold	26,255	–	–	0.24%	37
2018 Q3	$1.1M	Sell	26,255 -1,254	-5%	-$48.3K	0.22%	37
2018 Q2	$947K	Sell	27,509 -733	-3%	-$25K	0.2%	37
2018 Q1	$951K	Hold	28,242	–	–	0.21%	37
2017 Q4	$971K	Hold	28,242	–	–	0.2%	37
2017 Q3	$957K	Hold	28,242	–	–	0.2%	35
2017 Q2	$900K	Hold	28,242	–	–	0.2%	35
2017 Q1	$917K	Hold	28,242	–	–	0.2%	35
2016 Q4	$870K	Sell	28,242 -3,215	-10%	-$98.2K	0.2%	35
2016 Q3	$1.01M	Buy	31,457 +1,337	+4%	+$44.7K	0.23%	35
2016 Q2	$1.01M	Hold	30,120	–	–	0.23%	36
2016 Q1	$847K	Hold	30,120	–	–	0.2%	37
2015 Q4	$922K	Sell	30,120 -1,318	-4%	-$41.5K	0.22%	36
2015 Q3	$937K	Hold	31,438	–	–	0.24%	37
2015 Q2	$1M	Hold	31,438	–	–	0.24%	35
2015 Q1	$1.04M	Hold	31,438	–	–	0.25%	35
2014 Q4	$929K	Buy	31,438 +16	+0.1%	+$459	0.22%	36
2014 Q3	$882K	Hold	31,422	–	–	0.21%	37
2014 Q2	$885K	Hold	31,422	–	–	0.21%	36
2014 Q1	$958K	Hold	31,422	–	–	0.24%	34
2013 Q4	$913K	Hold	31,422	–	–	0.24%	32
2013 Q3	$856K	Hold	31,422	–	–	0.24%	31
2013 Q2	$835K	Buy	+31,422	New	+$868K	0.25%	32

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Professional Advisory Services's PFE Position: Q2 2026 in Review

Professional Advisory Services increased its Pfizer (PFE) stake by 0.43% in Q2 2026, buying an estimated $2.62K and bringing the position to 23,492 shares worth $566K. The position accounts for 0.07% of the portfolio, ranked #58.

Professional Advisory Services first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.65M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Professional Advisory Services held 23,492 shares of Pfizer worth $566K as of Q2 2026.
Professional Advisory Services bought 100 Pfizer shares in Q2 2026, an estimated $2.62K.
Pfizer made up 0.07% of Professional Advisory Services's portfolio in Q2 2026, its #58 holding.
Professional Advisory Services first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Professional Advisory Services's Pfizer position peaked at $1.65M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Professional Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.